Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration

References

• Borg D. C., Cotzias G. C. Manganese metabolism in man. Rapid exchange of 56Mn with tissue as demonstrated by blood clearance and liver uptake. J. Clin. Invest. 1958; 37: 1269
   PubMed Web of Science ®Google Scholar
• Brurok H., Schojtt J., Berg K., Karlsson J. O., Jynge P. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate-, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Invest. Radiol. 1995; 30: 159
   PubMed Web of Science ®Google Scholar
• Davidsson L., Cederblad A., Lönnerdal B., Sandström B. Manganese retention in man. A method for estimating manganese absorption in man. Am. J. Clin. Nutr. 1989; 49: 170
   PubMed Web of Science ®Google Scholar
• Dinoto D. R., Kennedy C. D., Johnson J. A., et al. Pharma-cokinetics and biotransformation of the MRI liver contrast agent mangafodipir trisodium injection in normal human male volunteers. 4th Int. 1 ISSX Meeting, Seattle, Washington, 1995; 8: 323
   Google Scholar
• Gallez B., Bacic G., Swartz H. M. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn. Reson. Imaging 1996; 35: 14
   Google Scholar
• Gerdin B., McCann E., Lundberg C., Arfors K. E. Selective tissue accumulation of manganese and its effect on regional blood flow and haemodynamics after intravenous infusion of its chloride salt in the rat. Int. J. Tissue React. 1985; 7: 373
   PubMedGoogle Scholar
• Gibbons R. A., Dixon S. N., Hallis K., Russell A. M., Sansom B. F., Symonds H. W. Manganese metabolism in cows and goats. Biochim. Biophys. Acta 1976; 444: 1
   PubMed Web of Science ®Google Scholar
• Grant D., Blazak W. F., Brown G. L. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 1997; 38: 759
   PubMed Web of Science ®Google Scholar
• Grant D., Toft K. G., Martinsen I., Atzpodien E. Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction. Acta Radiol. 1997; 38: 732
   PubMed Web of Science ®Google Scholar
• Grant D., Zech K., Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 1994; 29: S249
   PubMed Web of Science ®Google Scholar
• Hamm B., Vogl T. J., Branding G., et al. Focal liver lesions. MR imaging with Mn-DPDP — Initial clinical results in 40 patients. Radiology 1992; 182: 167
   PubMed Web of Science ®Google Scholar
• Jynge P., Brurok H., Asplund A., Towart R., Refsum H., Karlsson J. O. G. Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 740
   PubMed Web of Science ®Google Scholar
• Larsen L. E., Grant D. General toxicology of MnDPDP. Acta Radiol. 1997; 38: 770
   PubMed Web of Science ®Google Scholar
• Leach R. M., Lilburn M. S. Manganese metabolism and its function. World Rev. Nutr. Diet. 1978; 32: 123
   PubMedGoogle Scholar
• Malecki E. A., Radzanowski G. M., Radzanowski T. J., Gallaher D. D., Greger J. L. Biliary manganese excretion in conscious rats is affected by acute and chronic manganese intake but not by dietary fat. J. Nutr. 1996; 126: 489
   PubMed Web of Science ®Google Scholar
• McLachlan S. J., Eaton S., Desimone D. N. Pharmacok-inetic behaviour of gadoteridol injection. Invest. Radiol. 1992; 27: 12
   Web of Science ®Google Scholar
• Ni Y., Marchal G. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities. Acta Radiol. 1997; 38: 724
   PubMed Web of Science ®Google Scholar
• Ni Y., Petre C., Bosmans H., et al. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2. Acta Radiol. 1997; 38: 700
   PubMed Web of Science ®Google Scholar
• Onoda K., Hasegawa A., Sunouchi M., et al. Studies on the fate of poisonous metals in experimental animal (VII). Distribution and transplacental passage of manganese in pregnant rat and fetus. J. Food Hyg. Soc. 1978; 19: 208
   Google Scholar
• Rofsky N. M., Weinreb J. C., Bernardino M. E., Young S. W., Lee J. K., Noz M. E. Hepatocellular tumors. Characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993; 188: 53
   PubMed Web of Science ®Google Scholar
• Rowland M., Tozer T. N. Clinical pharmacokinetics. Concepts and applications, 2nd edn. Lea & Febiger, Philadelphia 1989
   Google Scholar
• Rummeny E., Ehrenheim C., Gehl H. B., et al. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Invest. Radiol. 1991; 26(Suppl. 1)S142
   PubMed Web of Science ®Google Scholar
• Rummeny E. J., Torres C. G., Kurdziel J. C., Nilsen G., Op De Beeck B., Lundby B. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol. 1997; 38: 638
   PubMed Web of Science ®Google Scholar
• Sherwin P. F., Hugo F. P., Robison R. O., et al. Safety, tolerance, and pharmacokinetics of high doses of gadodiamide injection, a nonionic magnetic resonance contrast agent. Acad. Radiol. 1994; 1: S2
   Google Scholar
• Southon T. E., Grant D., Bjørnerud A., et al. NMR relaxation studies with MnDPDP. Acta Radiol. 1997; 38: 708
   PubMed Web of Science ®Google Scholar
• Tirkkonen B., Aukrust A., Couture E., et al. Physico-chemical characterisation of mangafodipir trisodium. Acta Radiol. 1997; 38: 780
   PubMed Web of Science ®Google Scholar
• Toft K. G., Hustvedt S. O., Grant D., Friisk G. A., Skotland T. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Eur. J. Drug Metab. Pharm. 1997; 22: 65
   PubMed Web of Science ®Google Scholar
• Toft K. G., Hustvedt S. O., Grant D., et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 1997; 38: 677
   PubMed Web of Science ®Google Scholar
• Toft K. G., Kindberg G. M., Skotland T. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging. In vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharmaceut. Biomed. Anal. 1997; 15: 983
   PubMed Web of Science ®Google Scholar
• Torres C. G., Lundby B., Sterud A. Tufte, McGill S., Gordon P. B., Bjerknes H. Strand. MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol. 1997; 38: 631
   PubMed Web of Science ®Google Scholar
• Vogl T. J., Hamm B., Schnell B., et al. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J. Magn. Reson. Imaging 1993; 3: 51
   PubMed Web of Science ®Google Scholar
• Wang C., Gordon P. B., Hustvedt S. O., et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 1997; 38: 665
   PubMed Web of Science ®Google Scholar
• Weinmann H. J., Laniado M., Mutzel W. Pharmacokinetics of Gd-DTPA dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. 1984; 16: 167
   Google Scholar